Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 158   

Articles published

JNJ 88.09 +0.64 (0.73%)
price chart
5 Things I Learned Reading Johnson & Johnson's Annual Report
The irony here is that many investors admired companies like Johnson & Johnson for their exposure to international sales, which was seen as a hedge against a weakening dollar.
Related articles »  
Johnson & Johnson Unveils New Corporate Branding Campaign
So ends the new TV spot from TBWA LA for Johnson & Johnson, advertising not the company's baby shampoo or Band-Aids, per se, but the company itself.
Johnson & Johnson to introducing corporate branding campaign to burnish ...  Economic Times
J&J launches first corporate brand campaign  Marketing Week
Related articles »  
Trying to Burnish Its Image, J.&J. Turns to Emotions
FOR the corporate overseers at Johnson & Johnson, the last few years have been a challenge. Enlarge This Image. A scene from a commercial for Johnson & Johnson's campaign called For All You Love, its first global corporate branding campaign in 10 ...
Johnson & Johnson to Discontinue Metal-on-Metal Hip Products
Johnson & Johnson (JNJ) said it will discontinue its line of metal-on-metal replacement hips, exiting a product category that became the subject of regulatory scrutiny and thousands of customer lawsuits.
Johnson & Johnson Ending Metal-on-Metal Hip Implant Sales (2)
Johnson & Johnson (JNJ), the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S.
Correction to Thursday's Johnson & Johnson-Metal-on-Metal Hip ...  NASDAQ
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on ...  Mass Device
Related articles »  
Shareholders blast Johnson & Johnson management
NEW YORK Several Johnson & Johnson (JNJ) shareholders took the health care giant to task during its annual meeting, citing repeated product recalls, ethical lapses and excessive executive pay.
Related articles »  
Johnson & Johnson's Stock Looks Too Healthy - CNBC.com
While I have always liked health-care giant Johnson & Johnson, it's hard to recommend taking a position at these levels.
Related articles »  
Johnson & Johnson Unit Gets Priority Revenue for Simeprevir NDA
Johnson & Johnson (JNJ) unit Janssen Research and Development LLC said the U.S. Food and Drug Administration has granted priority review to its new drug application for simeprevir, its investigational treatment of genotype 1 chronic hepatitis C in ...
Janssen's experimental drug for hepatitis C gets FDA fast track  The Star-Ledger - NJ.com
Related articles »  
Ad of the Day: Johnson & Johnson
Johnson & Johnson's new corporate image work, from the Playa del Rey, Calif., office of TBWA\Chiat\Day, in some ways harkens back to its last major corporate push, the "Having a baby changes everything" campaign.
The Procter & Gamble Company (PG), Johnson & Johnson (JNJ): Billionaire Bill ...
Two of The Procter & Gamble Company (NYSE:PG)'s top competitors include Johnson & Johnson (NYSE:JNJ) and Colgate-Palmolive Company (NYSE:CL).
Related articles »